FDA inspection
Sanofi-Aventis Deutschland GmbH: FDA inspection ending May 14, 2019
FDA inspection 1094836 · Voluntary Action Indicated (VAI) · Frankfurt Am Main
Key facts
| Inspection ID | 1094836 |
|---|---|
| Firm | Sanofi-Aventis Deutschland GmbH |
| FEI number | 3003195501 |
| Address | Industriepark Hochst, Industriepark Hoechst, Bld K 703 |
| City | Frankfurt Am Main |
| Country | Germany |
| Fiscal year | 2019 |
| Inspection end date | May 14, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data